Research
Hormonal
Ketogenic diets are not recommended for Type 1 Diabetes or Gestational Diabetes due to safety concerns, lack of long-term data, and potential risks of DKA and fetal harm.
Do not use a ketogenic diet for Type 1 Diabetes or Gestational Diabetes. The risks of Diabetic Ketoacidosis (DKA) and potential harm to fetal development outweigh any potential glycemic benefits. Follow standard medical advice for these conditions.
StrongRefutesVERY_HIGH confidence
a nutritional approach, including ketogenic diets, to solely ‘treat’ T1D is unlikely to be efficacious and is arguably dangerous because of concerns surrounding greater risk of diabetic ketoacidosis (DKA) and hypoglycemia.
Why this rating
Based on position statements and lack of RCTs, indicating strong consensus against use.
Source
Does a Ketogenic Diet Have a Place Within Diabetes Clinical Practice? Review of Current Evidence and Controversies
Chloe Firman et al. · Diabetes Therapy · 2023
DOI 10.1007/s13300-023-01492-4
narrative_reviewCited 27×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →